Related Experiment Videos
Mitotic index and Alzheimer's disease
E C Jenkins1, L Ye, H Gu
1NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314-6399, USA.
Neuroreport
|January 6, 1999
Summary
Researchers found reduced mitotic index levels in skin cells of individuals with Alzheimer's disease (AD). This finding suggests skin fibroblast cultures could be a potential diagnostic indicator for AD.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) diagnosis relies on post-mortem brain examination for beta-amyloid plaques and neurofibrillary tangles.
- Current clinical diagnostic methods for AD lack simple, accessible laboratory tests.
Purpose of the Study:
- To investigate the potential of skin fibroblast cultures as a diagnostic indicator for Alzheimer's disease.
- To explore differences in mitotic index levels between AD patients and control groups.
Main Methods:
- Culturing skin fibroblasts from individuals with Alzheimer's disease and age-/sex-matched controls.
- Measuring and comparing mitotic index levels in these cultures.
- Assessing the effect of colcemid exposure on mitotic index levels.
Main Results:
- A consistent reduction in mitotic index was observed in skin fibroblast cultures from AD individuals compared to controls.
- The difference in mitotic index was statistically enhanced after overnight colcemid exposure (p = 0.04).
Conclusions:
- Skin fibroblast mitotic index levels show potential as a diagnostic biomarker for Alzheimer's disease.
- Further investigation into skin fibroblast cultures may lead to novel, non-invasive diagnostic tools for AD.